PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 201 filers reported holding PUMA BIOTECHNOLOGY INC in Q1 2015. The put-call ratio across all filers is 0.90 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $6,361,000 | +26.3% | 84,397 | +95.6% | 0.14% | +24.8% |
| Q2 2015 | $5,037,000 | -42.4% | 43,141 | +16.4% | 0.11% | -40.4% |
| Q1 2015 | $8,749,000 | +700.5% | 37,052 | +541.3% | 0.18% | +662.5% |
| Q4 2014 | $1,093,000 | -13.9% | 5,778 | +8.5% | 0.02% | -14.3% |
| Q3 2014 | $1,270,000 | -1.1% | 5,323 | -72.6% | 0.03% | 0.0% |
| Q2 2014 | $1,284,000 | +3.8% | 19,461 | +63.8% | 0.03% | +3.7% |
| Q1 2014 | $1,237,000 | -25.8% | 11,879 | -26.2% | 0.03% | -22.9% |
| Q4 2013 | $1,666,000 | – | 16,088 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 1,792,114 | $4,713,260 | 4.15% |
| Eversept Partners, LP | 1,681,149 | $4,421,422 | 0.37% |
| Camber Capital Management LP | 4,235,000 | $11,138 | 0.37% |
| Kynam Capital Management, LP | 473,975 | $1,246,554 | 0.20% |
| GLOBEFLEX CAPITAL L P | 538,559 | $1,416,410 | 0.17% |
| Affinity Asset Advisors, LLC | 202,349 | $532,178 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 279,629 | $735 | 0.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 363,666 | $956,442 | 0.06% |
| Patriot Financial Group Insurance Agency, LLC | 67,000 | $176,210 | 0.04% |
| ACADIAN ASSET MANAGEMENT LLC | 1,858,000 | $4,884 | 0.02% |